Issue Date | Title | Author(s) | Source | scopus | WOS | Fulltext/Archive link |
---|---|---|---|---|---|---|
2013 | A Phase I/IIa study of safety, tolerability, and pharma-cokinetic profiles of TG-2349, a pan-genotypic HCV protease inhibitor, in healthy East Asian and Caucasian subjects, and its antiviral activity in chronic hepatitis C patients | Tsai, Chen-En; Chang, Li-Wen; Chang, Yu-Ting; Hsu, Chiung-Yuan; Chen, Chih-Ming; Tsai, Cheng-Yuan; Lin, Chu-Chung; King, Chi-Hsin R.; Liu, Chun-Jen; Chen, Ding-Shinn; Hsu, Ming-Chu | Hepatology |